Quantcast
Channel: Becker's Spine Review
Viewing all articles
Browse latest Browse all 23847

K2M stock hits crucial point — 5 things to know

$
0
0

Spine device company K2M, which went public earlier this year, is at a critical moment for investors, according to an Equities report.

The stock hit a 52-week low last week, which could be viewed as positive or negative. Here are five quick facts on K2M stock:

 

1. The stock dropped to $13.04 per share on Sept. 26. By the closing bell, the stock was at $13.26 per share, a 1.92 percent loss.

 

2. The company saw 161,469 of its stock trade hands. Average daily volume is 109,502.

 

3. The Russell 2000 Index includes K2M Group Holdings as a component, which is viewed as a "reliable indicator of the health of the broad small cap market," according to the report.

 

4. Bearish investors see the low point as a sign of growing downward momentum — leading them to sell shares — but bullish investors anticipate a bounce after the stock hits its low point.

 

5. On Sept. 29, K2M stock opened at $13.17 with a market cap at $487 million. The company's share volume is 28,571, compared with the 50-day average daily share volume at 98,978.

 

More articles on orthopedic devices:
DePuy Synthes, SpineGuard, Baxano & more-23 key notes
Eminent Spine launches lumbar plate system
ReWalk Robotics prices IPO at $12


Viewing all articles
Browse latest Browse all 23847

Trending Articles